Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


TriVascular boosted by $60m financing round

This article was originally published in Clinica

Executive Summary

Endovascular graft firm TriVascular has secured $60m in funding, which it will use to commercialise its Ovation abdominal stent graft system in Europe. The company closed a series C financing round, which was led by new investor Pinnacle Ventures. Existing investors New Enterprise Associates, Delphi Ventures, MPM Capital and Kearny Venture Partners also contributed. TriVascular (Santa Rosa, California) will use proceeds from the financing to launch Ovation in Europe, drive clinical research activity across three continents and fund next-generation product development. The Ovation system is designed to treat abdominal aortic aneurysm (AAAs), which affects nearly two million people in the US, according to TriVascular.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts